We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOMA
3976
DELISTED
Doma Holdings, Inc.
DOMA
-17,839
Closed -$970K
CVT
3977
DELISTED
Cvent Holding Corp. Common Stock
CVT
-231,208
Closed -$1.66M
RUTH
3978
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-60,447
Closed -$1.38M
STET.U
3979
DELISTED
ST Energy Transition I Ltd. SAIL securities, each consisting of one Class A ordinary share and one-half of one redeemable warrant
STET.U
-300,000
Closed -$3M
SPCMU
3980
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
-250,000
Closed -$2.52M
SEAC
3981
DELISTED
Seachange International Inc
SEAC
-1,026
Closed -$24K
BIOC
3982
DELISTED
Biocept, Inc.
BIOC
-3,094
Closed -$215K
TGR.U
3983
DELISTED
Kimbell Tiger Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TGR.U
-716,849
Closed -$7.26M
MAXR
3984
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-49,320
Closed -$1.95M
OSH
3985
DELISTED
Oak Street Health, Inc.
OSH
-64,873
Closed -$1.74M
CSII
3986
DELISTED
Cardiovascular Systems, Inc.
CSII
-14,277
Closed -$323K
AMYT
3987
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
-12,994
Closed -$108K
VLTA
3988
DELISTED
Volta Inc.
VLTA
-16,430
Closed -$50K
DCT
3989
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
-229,734
Closed -$5.08M
LYLT
3990
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
-36,345
Closed -$601K
BOXD.WS
3991
CALL
DELISTED
Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share
BOXD.WS
-229,243
Closed -$2.33M
FSTX
3992
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-10,456
Closed -$37K
OPNT
3993
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
-13,584
Closed -$291K
CPAQU
3994
DELISTED
Counter Press Acquisition Corporation Unit
CPAQU
-200,000
Closed -$2.02M
SRNE
3995
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-1,658,516
Closed -$3.86M
KNBE
3996
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
-1,114,429
Closed -$25.7M
IVC
3997
DELISTED
Invacare Corporation
IVC
-231,913
Closed -$327K
SJI
3998
DELISTED
South Jersey Industries, Inc.
SJI
-13,434
Closed -$464K
AYLA
3999
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
-23,872
Closed -$95K
MMX
4000
DELISTED
Maverix Metals Inc. Common Shares
MMX
-51,995
Closed -$250K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.